RARRES2 and dilated cardiomyopathy: In 2190 participants from the EPIC-Potsdam cohort [16], 214 patients with dilated cardiomyopathy [20], 834 patients with chronic heart failure [21], and 77 patients with proven coronary artery disease [23], circulating chemerin was positively associated with the risk of major cardiac events.